This integrative study identifies BCL6, DUSP3, and IL6R as shared immune-regulatory genes in AF and ATH, with transcriptomic and in vitro evidence supporting their pathogenic role and potential as dual-disease therapeutic targets. Here, BCL6 is linked to atrial fibrillation.